immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
Published 6 years ago • 273 plays • Length 7:40Download video MP4
Download video MP3
Similar videos
-
3:07
car t-cell therapy: cancer immunotherapy beyond checkpoint inhibitors
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
11:19
immunotherapy for aml & all
-
1:20
new strategies in aml: checkpoint inhibitors combined with t-cell engagers
-
1:12
key challenges in immunotherapy for aml
-
3:47
the role of immunotherapy in the aml treatment landscape
-
2:41
immunotherapy in aml: azacitidine plus checkpoint inhibitors
-
1:29
blinatumomab in combination with checkpoint inhibitors for all
-
1:27
exciting advances in checkpoint inhibitors, car t-cells and alk inhibitors
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
9:55
immune checkpoint inhibitors in acute leukemia
-
5:20
immuno-oncology agents for mm: checkpoint inhibitors and nk-cells
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
1:53
toxicities and new immune checkpoint inhibitors
-
7:32
current immune checkpoint inhibitor trials in aml/mds
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
1:15
an exciting era for immunotherapy for r/r all
-
1:48
the challenges of choosing the right target antigen in aml compared to all
-
2:48
key targets and the future of immunotherapy in aml